Shanghai Yizhong Pharmaceutical Co Ltd Tangible Net Worth Ratio
Shanghai Yizhong Pharmaceutical Co Ltd tangible net worth ratio. Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Tangible Net Worth Ratio of 98.0% as of September 2025. This metric is calculated by deducting intangible assets (CN¥28.85 Million) from net assets (CN¥1.46 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 688091 net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Shanghai Yizhong Pharmaceutical Co Ltd (2017–2024)
Tangible net worth ratio of Shanghai Yizhong Pharmaceutical Co Ltd from 2017 to 2024. This chart shows how Shanghai Yizhong Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 98.0%, reflecting net assets of CN¥1.46 Billion with intangible assets of CN¥28.85 Million CNY.
Shanghai Yizhong Pharmaceutical Co Ltd Tangible Net Worth Ratio by Year (2017–2024)
Shanghai Yizhong Pharmaceutical Co Ltd tangible net worth ratio by year from 2017 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Shanghai Yizhong Pharmaceutical Co Ltd from 2017 to 2024, covering 8 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market value of Shanghai Yizhong Pharmaceutical Co Ltd.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 99.4% | CN¥1.41 Billion | CN¥8.36 Million | CN¥1.45 Billion | ▼ 0.0 pp |
| 2023 | 99.4% | CN¥1.46 Billion | CN¥8.58 Million | CN¥1.57 Billion | ▲ +0.1 pp |
| 2022 | 99.3% | CN¥1.32 Billion | CN¥8.79 Million | CN¥1.35 Billion | ▲ +0.1 pp |
| 2021 | 99.2% | CN¥1.18 Billion | CN¥9.01 Million | CN¥1.20 Billion | ▲ +3.0 pp |
| 2020 | 96.2% | CN¥243.51 Million | CN¥9.23 Million | CN¥258.81 Million | ▼ -0.2 pp |
| 2019 | 96.4% | CN¥265.35 Million | CN¥9.44 Million | CN¥277.62 Million | ▲ +1.0 pp |
| 2018 | 95.4% | CN¥212.18 Million | CN¥9.66 Million | CN¥229.33 Million | ▲ +0.4 pp |
| 2017 | 95.0% | CN¥197.57 Million | CN¥9.88 Million | CN¥213.74 Million | — |